142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Transformative programs for the health and safety of cities

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 11:30 AM - 11:50 AM

Charlie Branas, PhD , Professor of Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
With colleagues at the University of Pennyslvania Urban Health Lab (www.urbanhealthlab.org), the CDC, the NIH, and various municipalities, Dr. Branas has been scientifically investigating a variety of place-based changes to cities, seeking to find high-impact, sustainable solutions that can transform the health and safety of cities.  Through various studies, including randomized trials, his lab has shown that the greening of vacant urban spaces, as well as the remediation of abandoned buildings and other forms of urban blight reduction, are potentially transformative programs for the health and safety of cities.

Learning Areas:

Basic medical science applied in public health
Environmental health sciences
Planning of health education strategies, interventions, and programs
Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Discuss effective components of programs that reduce urban blight

Keyword(s): Violence & Injury Prevention, Urban Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Professor of Epidemiology at the University of Pennsylvania. I work to improve health and healthcare and I am recognized for my efforts to reduce violence and enhance emergency care. Much of my work incorporates human geography and spatial interactions. I have presented the findings from my studies in cities and small towns across the US and numerous other countries throughout the world.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.